Jeito Capital Becomes Major Investor in SparingVision as Part of €44.5 Million Financing

Paris, France, Oct. 21 (Korea Bizwire) – Jeito Capital (“Jeito”), a rapidly emerging independent investor dedicated to biotech and biopharma, today announces that it has become a major investor in SparingVision, a French preclinical stage biotech company focused on gene therapy in ophthalmology. The €44.5 million financing round brought together new investors alongside Jeito including [...]